The 20 Best Cutaneous T-Cell Lymphoma (CTCL) Doctors Near Me in Brighton, MI
Find the Top Cutaneous T-Cell Lymphoma (CTCL) Experts and Specialists
Brighton Center For Specialty Care
Dr Joseph Evans is originally from the Chicago suburbs, and attended the University of Iowa where he graduated with a Bachelor of Science degree in Physics. He then completed the MD-PhD program at Northwestern University Feinberg School of Medicine, where his graduate studies focused on inhibitors of cell death in cancer cells. Dr Evans entered Radiation Oncology at University of Michigan where he completed Residency.Clinically, Dr Evans sees and treats patients with gynecologic cancer, including brachytherapy, spine metastases, and benign diseases treated with radiation treatment, particularly Dupuytren's disease.Dr Evans is a physician leader in the department and the Rogel Cancer Center. He works with other faculty and staff leaders on clinical operations within the department and the interface with the Cancer Center, focusing on process improvement, quality metrics, financial stewardship, and strategy. His work streamlines workflows in the Electronic Medical Record (Epic) to improve patient care, patient experience, and clinician experience. Dr. Evans is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Prostate Cancer. Dr. Evans is board certified in Radiation Oncology.
Dr. Jennifer Mancuso a board-certified dermatologist, and fellowship-trained pediatric dermatologist who provides medical dermatology diagnosis and treatment to patients of all ages. Dr. Mancuso sees patients in our medical dermatology outpatient clinics, including our pediatric dermatology clinic at C.S. Mott Children’s Hospital. In addition, Dr. Mancuso provides dermatology consultation within the Michigan Medicine hospitals and emergency department.Dr. Mancuso is a clinical assistant professor in the departments of dermatology and pediatrics. She received her medical degree from Wayne State University School of Medicine in Detroit, Michigan. Following graduation, Dr. Mancuso completed her transitional year internship and her dermatology residency at Henry Ford Hospital, where she served as Chief Resident in her final year. Dr. Mancuso joined the University of Michigan Department of Dermatology faculty in 2018 and subsequently completed a fellowship in pediatric dermatology at Rady Children’s Hospital in San Diego, California in 2020. Dr. Mancuso is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 75 other conditions, according to our data. Her clinical expertise encompasses DRESS Syndrome, Hidradenitis Suppurativa, Keratosis Pilaris, and Vascular Birthmark.
Brighton Center For Specialty Care
Dr. Dragovic attended the University of Michigan for both undergraduate and medical school, and after completing radiation oncology residency at the University of Alabama at Birmingham (UAB), he returned to Ann Arbor to join the U of M Department of Radiation Oncology faculty in 2012. Since that time, he has held several roles in the Department of Radiation Oncology, with experience in multiple of the department’s community practice affiliates as well as at the main hospital. Dr. Dragovic was chosen to lead the department’s new clinic at the Brighton Center for Specialty Care and also to represent the BCSC Cancer Center as a whole as Physician Lead. He has taken on these roles with great joy and pride as it has been both a challenge and reward being a part of building a new cancer center. Dr. Dragovic’s vision for the BCSC Cancer Center is to become more or less an extension of the University Hospital Cancer Center- providing the highest quality multidisciplinary care to patients with a wide variety of cancer diagnoses, including the availability of clinical trial enrollment for appropriate patients. Clinically, Dr. Dragovic treats all disease sites and has a specific clinical interest in head & neck cancer, lung cancer, and stereotactic body radiotherapy (SBRT). Dr. Dragovic is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Laryngeal Cancer, and Breast Cancer. Dr. Dragovic is board certified in Radiation Oncology.
Brighton Center For Specialty Care
Following her undergraduate and graduate studies in Virginia, Dr. Jaworski completed her residency training in Radiation Oncology at the University of Michigan. Dr. Jaworski has closely collaborated with clinical and medical physics faculty members to investigate multiple aspects of radiation treatment planning, including collaborations within the Michigan Radiation Oncology Quality Consortium. Her first-author publications have shown the durable impact of quality measures in reducing the use of prolonged radiation courses for pain relief, gains associated with automated treatment planning for head and neck cancer, and reducing toxicities associated with radiation. As a testament to her passion for patient care and clinical focus, Dr. Jaworski was inducted into the Gold Humanism Honor Society in 2022. Dr. Jaworski is board-eligible and treats all disease sites. Dr. Jaworski is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). Her clinical expertise encompasses Bone Tumor, Prostate Cancer, HER-2 Positive Breast Cancer, and Endometrial Cancer. Dr. Jaworski is board certified in Radiation Oncology.
Dr. Mio Nakamura is a board-certified dermatologist and an assistant professor of dermatology. She provides medical dermatology diagnosis and treatment to patients of all ages within in our medical dermatology outpatient clinics. Dr. Nakamura maintains a strong interest in clinical research and serves as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department. In this role, she oversees patient recruitment and participation in clinical and translational studies.Dr. Nakamura is a graduate of Wayne State University School of Medicine. Following graduation, she completed her transitional year internship at St. Joseph Mercy Health System in Ann Arbor, MI, and a Psoriasis and Clinical Research Fellowship in the Department of Dermatology at the University of California San Francisco, in San Francisco, CA. Dr. Nakamura obtained her Masters of Science in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health. She completed her dermatology residency at the U-M Department of Dermatology, where she served as co-chief resident in her final year. Dr. Nakamura joined the U-M dermatology faculty in September 2021. Dr. Nakamura is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Psoriasis, Plaque Psoriasis, Melanoma, and Actinic Keratosis. Dr. Nakamura is board certified in Dermatology.
Ethan Sagher is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Sagher is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Warts, Actinic Keratosis, Mycosis Fungoides, and Seborrheic Keratosis.
DMC Huron Valley-Sinai Hospital
Stephen Schwartz is an Oncologist practicing medicine in Commerce Township, Michigan. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Anemia, Familial Colorectal Cancer, Colorectal Cancer, and Endoscopy.
Last Updated: 04/28/2026




